- Investing Ideas
- Swedish Pharmaceuticals & Biotech Pure Equity Growth
Swedish Pharmaceuticals & Biotech Pure Equity Growth
Results
3
0 new
Companies that has zero debt on their balance sheet and is forecast to grow at an exponential rate in the future.
3 companies
Camurus
Market Cap: SEK 32.6b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 547.50
7D
5.5%
1Y
-7.8%
BioArctic
Market Cap: SEK 27.5b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 309.80
7D
3.5%
1Y
75.5%
Bonesupport Holding
Market Cap: SEK 13.6b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 207.20
7D
-1.6%
1Y
-24.2%